Jan Alan Alfheim, Øyvind Sverre Bruland
Total investments received (USD) - 25M
- Feb 2017 -
Oncoinvent AS is a privately held Norwegian company and is based in Oslo, Norway. The company is committed to developing new innovative products in order to provide better treatment options to cancer patients.
The company's founders started Oncoinvent in 2010 with a view to designing better cancer treatments by applying known physical and chemical principles of selected novel materials in new ways in order to maximize their medical benefit while minimizing potential safety concerns. This approach has allowed the company to develop a rich development pipeline and to explore multiple technological avenues before selecting a lead product candidate for preclinical testing.